New Tool Can Predict Individuals Dementia Risk
FRIDAY, Nov. 18, 2022 -- A risk score tool can accurately predict an individual’s 13-year dementia risk, according to a study published online Nov. 17 in JAMA Network Open.
Lina Ren, from Shenzhen Mental
There Might Be a Perfect Indoor Humidity to Curb COVID Spread
By Dennis Thompson HealthDay Reporter
FRIDAY, Nov. 18, 2022 -- It’s sort of like the Goldilocks principle — a room that’s either too dry or too humid can influence transmission of COVID-19
FDA Approves Tzield
FDA Approves Tzield (teplizumab-mzwv) to Delay the Onset of Stage 3 Type 1 Diabetes
Tzield is the first disease-modifying therapy in T1D, a life-threatening autoimmune disease
In a clinical trial, in Stage 2 T1D patients, Tzield d
FDA Approves New Fully Liquid Presentation of GSK’s Rotarix Vaccine to Prevent Gastroenteritis Caused by Rotavirus
New fully liquid formulation of Rotarix removes the need to reconstitute prior to administration, for improved convenience
Clinical data d
Kineret authorized for emergency use by FDA for the treatment of COVID-19 related pneumonia
STOCKHOLM, Nov. 10, 2022. Sobi today announced that the US Food and Drug Administration has granted Emergency Use Authorization (EUA) for the use of Kineret® (ana
Brain Bleeds Up in Patients With COVID-19 Treated for Ischemic Stroke
THURSDAY, Nov. 10, 2022 -- Patients with acute ischemic stroke who also have COVID-19 have higher rates of intracranial bleeding complications and worse clinical outcomes following rev